|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.78 USD | -3.26% |
|
-2.20% | -11.88% |
| Mar. 13 | Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
| Mar. 13 | Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M | MT |
Aadi Bioscience, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 1.12 million compared to USD 14.58 million a year ago. Net loss was USD 110.09 million compared to USD 3.48 million a year ago.
Basic loss per share from continuing operations was USD 12.41 compared to USD 1.76 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.88% | 43.71M | |
| -2.86% | 87.31B | |
| +3.95% | 40.86B | |
| -21.94% | 29.36B | |
| +53.99% | 24.49B | |
| -5.41% | 17.31B | |
| -44.23% | 11.26B | |
| -17.60% | 11.62B | |
| -13.96% | 11.31B | |
| +5.24% | 8.31B |
AADI BIOSCIENCE, INC. 
